Literature DB >> 10993440

Acinar-islet cell tumor of the pancreas: report of a malignant pancreatic composite tumor.

T Muramatsu1, H Kijima, T Tsuchida, M Konagaya, H Matsubayashi, N Tada, M Nakamura, Y Ueyama.   

Abstract

An unusual case of malignant pancreatic composite tumor with both components of acinar cell tumor (ACT) and islet cell tumor (ICT) was investigated histologically, immunohistochemically, and ultrastructurally. The pancreatic tumor with central cyst formation was found on computerized tomographic examination of a 72-year-old man reporting appetite and weight loss. The ACT component was present in the original pancreatic region and the ICT region was adjacent to the ACT. ACT was immunohistochemically positive for pancreatic amylase, whereas ICT had argyrophil tumor cells immunohistochemically positive for chromogranin A. There were several tumor cell nests positive for both pancreatic amylase (acinar differentiation) and chromogranin A (islet differentiation). We speculated that ICT may have arisen from the de-differentiated tumor cells in the ACT after the occurrence of ACT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993440     DOI: 10.1097/00004836-200009000-00020

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  2 in total

1.  Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case.

Authors:  Shinjiro Kobayashi; Takeshi Asakura; Nobuyuki Ohike; Takeharu Enomoto; Joe Sakurai; Satoshi Koizumi; Taiji Watanabe; Hiroshi Nakano; Takehito Otsubo
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.